Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-09

FDA Approved: LAMOTRIGINE — Supplemental Application (Ascend Laboratories, LLC)

View source ↗

Summary

FDA approved a supplemental application for lamotrigine from Ascend Laboratories, granting approval for a generic lamotrigine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)